Cleared Traditional

K223629 - SpiroSphere, SpiroSphereECG, CardioSphere (FDA 510(k) Clearance)

May 2024
Decision
540d
Days
Class 2
Risk

K223629 is an FDA 510(k) clearance for the SpiroSphere, SpiroSphereECG, CardioSphere. This device is classified as a Calculator, Predicted Values, Pulmonary Function (Class II - Special Controls, product code BTY).

Submitted by Eresearchtechnology GmbH (Estenfeld, DE). The FDA issued a Cleared decision on May 28, 2024, 540 days after receiving the submission on December 5, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 868.1890.

Submission Details

510(k) Number K223629 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 2022
Decision Date May 28, 2024
Days to Decision 540 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code BTY - Calculator, Predicted Values, Pulmonary Function
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.1890